Olanzapine OD Tablets 5 mg
Phase 1Completed 0 views this week 0 watching💤 Quiet
Interest: 26/100
26
Development Stage
✓
Pre-clinical2
Phase 13
Phase 24
Phase 35
ApprovedIndication / Disease
Fasting
Conditions
Fasting
Trial Timeline
Nov 1, 2006 → Dec 1, 2006
NCT ID
NCT01503437About Olanzapine OD Tablets 5 mg
Olanzapine OD Tablets 5 mg is a phase 1 stage product being developed by Dr. Reddy's Laboratories for Fasting. The current trial status is completed. This product is registered under clinical trial identifier NCT01503437. Target conditions include Fasting.
Hype Score Breakdown
Clinical
6
Activity
8
Company
12
Novelty
0
Community
0
Clinical Trials (2)
| NCT ID | Phase | Status |
|---|---|---|
| NCT01503450 | Phase 1 | Completed |
| NCT01503437 | Phase 1 | Completed |
Competing Products
20 competing products in Fasting